Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Whole genome sequence analysis for acute lymphoblastic leukaemia

Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA
Whole genome sequence analysis for acute lymphoblastic leukaemia ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )
26 Jun 2012

Use of mesenchymal stromal cells against graft-versus-host disease

Prof Willem Fibbe – Lieden University Medical Center, Holland
Use of mesenchymal stromal cells against graft-versus-host disease (  Prof Willem Fibbe – Lieden University Medical Center, Holland )
26 Jun 2012

Next generation sequencing and the monoclonal structure of multiple myeloma

Dr Niccolo Bolli – University of Cambridge, UK
Next generation sequencing and the monoclonal structure of multiple myeloma ( Dr Niccolo Bolli – University of Cambridge, UK )
26 Jun 2012

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland
Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )
25 Jun 2012

How malignant cells in patients with CLL escape T-cell recognition

Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK
How malignant cells in patients with CLL escape T-cell recognition ( Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK )
22 Jun 2012

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA
Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )
19 Jun 2012

MEK inhibitor, trametinib, improves progression free survival in melanoma

Dr Caroline Robert – Institute Gustave Roussy, Paris, France
MEK inhibitor, trametinib, improves progression free survival in melanoma ( Dr Caroline Robert – Institute Gustave Roussy, Paris, France )
18 Jun 2012

Drug development in small cell and non-small cell lung cancer

Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA
Drug development in small cell and non-small cell lung cancer ( Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA  )
18 Jun 2012

Early phase trial of ibrutinib for chronic lymphocytic leukaemia

Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA
Early phase trial of ibrutinib for chronic lymphocytic leukaemia ( Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA )
18 Jun 2012

How malignant cells in patients with CLL escape T-cell recognition

Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK
How malignant cells in patients with CLL escape T-cell recognition ( Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK )
15 Jun 2012

Clinical trials for rare tumour types

Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA
Clinical trials for rare tumour types ( Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Jun 2012

First line treatment against metastatic breast cancer

Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada
First line treatment against metastatic breast cancer ( Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada )
15 Jun 2012